DURHAM, N.C., Jan. 4, 2016 – SciMetrika, a Durham-based population health consulting company, has acquired the assets of the Institute for Chemical Safety Sciences (ICSS), a division of The Hamner Institutes for Health Sciences in Research Triangle Park, North Carolina, through its wholly owned subsidiary, ScitoVation. The acquisition presents new opportunities for the SciMetrika group to expand into cell-based science and serve a broader range of customers in the commercial sector.

In addition to the assets acquired from ICSS, former members of ICSS leadership and staff have joined ScitoVation. Their decision comes on the heels of The Hamner Institutes’ announcement that it would cease most operations as of December 31, 2015. After engaging in a search for potential partner companies, the former ICSS team believed that aligning with SciMetrika presented the best opportunity due to SciMetrika’s outstanding reputation and thought leadership within the population health community and life sciences industry as a whole.

With the acquisition of ICSS assets, SciMetrika and ScitoVation inherit a brain trust in chemical safety science. SciMetrika will benefit from the ability to conduct research and development work from the former ICSS laboratory space, and the opportunity to move into private sector population health ventures. Under the new structure, former ICSS staff will expand their current footprint on chemical safety sciences through the development of research tools, processes and technologies using human cell-based and computational methods.

ScitoVation will operate with the previous ICSS scientific leadership and staff, who became ScitoVation employees effective Jan. 1. As part of SciMetrika’s commitment to a seamless transition, employees will continue to work in their former space at The Hamner Institutes, with procedures and processes intact. The expanded skill sets will enable both companies to leverage synergies and serve a broader range of customers including the chemical, agribusiness, consumer product and pharmaceutical industries. For government clients, the expanded skill sets give SciMetrika the ability to provide additional expertise in the use of innovative tools for safety and risk assessment.

ScitoVation and its acquisition of the ICSS assets will advance life sciences research and overall population health through the development of strategies that make use of cell-based assays rather than animal experimentation. With a focus on creating better tools to assess safety and effectiveness, ScitoVation will improve knowledge of modes of action and enhance human relevance.

For more information on SciMetrika, visit http://scimetrika.com. For more information about ScitoVation, visit http://scitovation.com.

QUOTES:

“Through ScitoVation, SciMetrika continues its mission to improve human health by becoming a leader in the conduct of studies using human cells and computational models,” said Dr. Jean Orelien, founder and CEO of SciMetrika. “Both SciMetrika and former ICSS staff who are now part of ScitoVation share the same passion for improving human health through their work.”

“Our alignment with SciMetrika will allow us to expand our research capabilities and explore new avenues for our chemical safety work,” said Rebecca Clewell, Ph.D., former ICSS director and chief scientific officer for ScitoVation. “The staffs of both the new ScitoVation and SciMetrika are working hard to ensure that our operations seamlessly transition and that we are able to increase our collaboration to strengthen the services we offer clients, as well as our thought leadership in life sciences.”

NEW MEDIA CONTENT:

SciMetrika Facebook page:

https://www.facebook.com/scimetrika

SciMetrika Twitter feed:

https://twitter.com/SciMetrika

SciMetrika LinkedIn page:

https://www.linkedin.com/company/scimetrika-llc

ScitoVation Facebook page:

https://www.facebook.com/scitovation

ScitoVation Twitter feed:

https://twitter.com/ScitoVation

ScitoVation LinkedIn page:

https://www.linkedin.com/company/scitovation

ABOUT SCIMETRIKA:

SciMetrika, LLC, is a population health consulting company providing scientific, technical, and technology solutions for federal, state, and local agencies; commercial companies; academic institutions; and private research organizations. Since its founding, the company has had a singular focus on improving human health. The company’s comprehensive services include conduct of population-based studies along with program development, implementation and evaluation. SciMetrika was founded in 2001 and is based in Durham, North Carolina, with additional offices in Atlanta, Georgia and Silver Spring, Maryland.

ABOUT SCITOVATION:

ScitoVation is a wholly owned, independently operating subsidiary of SciMetrika, LLC, a leading company in the field of population health. The mission of ScitoVation, formed in connection with SciMetrika’s acquisition of Institute for Chemical Safety Sciences (ICSS) assets, is to improve chemical safety and science through development of testing strategies, cell-based assays, computational models, and quantitative analytical tools that lead to safer or more effective therapies. ScitoVation is based in Research Triangle Park, North Carolina, one of the United States’ premier research and development hubs.